HCA
HCA Healthcare, Inc
HCA Healthcare, Inc historical holders
total: 11
Scion Asset Management HCA Healthcare, Inc transactions over time
- Total transactions:
- 8
- New positions:
- 3
- Sold out:
- 3
- Added:
- 2
- Held since:
- 2024 Q4
- Held for:
- 1 quarter
- Latest activity:
- 2025 Q1
Michael Burry has been an institutional investor in HCA Healthcare, Inc (HCA) since 2015 Q4. According to 2025 Q3 report, Michael Burry doesn't hold any shares. The fund/company first acquired HCA in 2015 Q4, initially purchasing 75,000 shares. Michael Burry later completely sold out the position and reinvested in HCA again in 2024 Q4. Since the initial investment, Scion Asset Management has made 7 more transactions in this position.
When did Michael Burry exit their HCA position?
Michael Burry no longer holds HCA Healthcare, Inc (HCA). They sold off their entire position in 2025 Q1, closing out an investment that began in 2015 Q4.
When did Michael Burry first invest in HCA?
Michael Burry first invested in HCA Healthcare, Inc (HCA) in 2015 Q4 at the reported quarter-end price of $67.63 per share, acquiring 75,000 shares in their initial purchase.
What is Michael Burry's average cost basis for HCA?
Based on historical transaction data, Michael Burry's estimated cost basis for HCA Healthcare, Inc (HCA) is approximately $300.15 per share. This represents their average reported price* across all buy transactions.
Has Michael Burry reinvested in HCA after selling?
Yes, Michael Burry has shown renewed interest in HCA Healthcare, Inc (HCA). After completely selling their position, they reinitiated an investment in 2024 Q4, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $300.15
- Weighted AVG sell price:
- $300.15
HCA transactions history by Scion Asset Management
8 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q1
|
0.00%
|
0
|
$300.15
|
|
-100% (-15,000)
|
-5.81%
|
|
2024 Q4
|
5.81%
|
15,000
|
$300.15
|
$4,502,250
|
new
|
+5.81%
|
|
2024 Q2
|
0.00%
|
0
|
$333.53
|
|
-100% (-25,000)
|
-8.06%
|
|
2024 Q1
|
8.06%
|
25,000
|
$333.53
|
$8,338,250
|
+25.00% (+5,000)
|
+1.61%
|
|
2023 Q4
|
5.72%
|
20,000
|
$270.68
|
$5,413,600
|
new
|
+5.72%
|
|
2018 Q4
|
0.00%
|
$75.63
|
-100% (-100,000)
|
|||
|
2016 Q1
|
15.28%
|
$78.05
|
+33.33% (+25,000)
|
|||
|
2015 Q4
|
6.34%
|
$67.63
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.